Infectious Disease Rapid Diagnostic Testing Market Size 2021, will show Lucrative Growth with steady CAGR 2021-2030 - EIN Presswire

2022-08-27 14:49:36 By : Ms. Sherry Chen

There were 712 press releases posted in the last 24 hours and 218,283 in the last 365 days.

Increasing prevalence of infectious diseases, COVID-19 pandemic & need for more efficient & rapid diagnostics are some key factors driving market revenue growth

VANCOUVER, BC, CANADA, August 1, 2022 /EINPresswire.com/ -- The global Infectious Disease Rapid Diagnostic Testing Market size is expected to reach USD 51.01 Billion in 2030 and register a revenue CAGR of 7.0% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of infectious diseases and emergence of COVID-19 are some key factors driving market revenue growth. Prevalence of infectious diseases has been rising, in both developed and developing countries, and resulting in steady demand for infectious disease rapid diagnostic testing. Following the pandemic, the need to identify and monitor infectious diseases has been placed on significantly high importance and has driven major increase in demand for testing kits. Moreover, rising preference for preventive care is expected to increase need for infectious disease diagnostics over the forecast period. Large-scale population-based testing is necessary to strengthen COVID-19 preventive and control efforts and measures, which is expected to continue to drive increased demand for infectious disease diagnostic products in future.

Rise in number of cases of Severe Acute Respiratory Syndrome  Coronavirus-19 (SARS-Cov-19) has led to increased demand for infectious disease rapid diagnostic testing products globally. Presently, majority of countries are focusing on flattening the curve of community transmissions of coronavirus, which is driving demand for diagnostics products. Another factor driving product demand is scale-up of manufacturing capabilities by market players to meet rising product demand in the current scenario, as well as to prepare for future situations.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/269

Prominent Players Analyzed in the Report:

Abbott Laboratories, Danaher Corporation, BGI Group, DiaSorin S.p.A, F. Hoffmann-La Roche Ltd., Luminex Corporation, bioMérieux S.A., Hologic, Inc., Thermo Fisher Scientific Inc., and Becton, Dickinson, and Company, among others.

Some Key Highlights from the Report

Bio-Rad Laboratories, in February 2020, acquired Exact Diagnostics of Fort Worth. The acquisition helped the company gain accessibility to a catalog of molecular quality control products in virology, microbiology, respiratory, transplant vector-borne, and sexually transmitted infections.

North America is expected to witness several growth opportunities resulting in an increase in the level of awareness among consumers. The presence of a large number of educational institutes, corporate buildings, hospitals, and also a rise in the self-hygiene among people will significantly impact the industry’s growth.

The lateral flow assay is among the most popular diagnostic tool that meets the requirement of colorimetric assays. It is an ideal diagnostic test, including features such as easy operation, less time consumption, durable stability, and low cost for the POC test.

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/infectious-disease-rapid-diagnostic-testing-market

Emergen Research has segmented the global Infectious Disease Rapid Diagnostic Testing Market on the basis of product type, deployment mode, application, end-users, and region:

Product Outlook (Revenue, USD Billion; 2017-2027)

Technology Outlook (Revenue, USD Billion; 2017-2027)

Isothermal Nucleic Acid Amplification Technology (INAAT)

Disease Outlook (Revenue, USD Billion; 2017-2027)

End-User Outlook (Revenue, USD Billion; 2017-2027)

Request a discount on the report @ https://www.emergenresearch.com/request-discount/269

Regional Outlook (Revenue, USD Billion; 2017-2027)

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/269

Overview of the Infectious Disease Rapid Diagnostic Testing Market Report:

Introduction, Product Scope, Market Overview, and Opportunities

Analysis of the Manufacturers with sales, revenue, and price analysis

Comprehensive analysis of the competitive landscape

Extensive profiling of the key competitors along with their business strategies and market size

Regional analysis of the market along with sales, revenue, market share, and global position

Country-wise analysis of the market along with types, applications, and manufacturing

Strategic recommendations to established players as well as new entrants

In-depth analysis of the risks, restraints, and limitations in the Infectious Disease Rapid Diagnostic Testing industry

Thank you for reading our report. Please connect with us to know more about the report or the customization of the report. Our team will ensure the report is best suited to meet your requirements.

Radiation Therapy in Oncology Market

https://www.emergenresearch.com/industry-report/radiation-therapy-in-oncology-market

https://www.emergenresearch.com/industry-report/photodynamic-therapy-market

https://www.emergenresearch.com/industry-report/green-funerals-market

Data Center Liquid Cooling Market

https://www.emergenresearch.com/industry-report/data-center-liquid-cooling-market

https://www.emergenresearch.com/industry-report/multi-modal-imaging-market

https://www.emergenresearch.com/industry-report/structural-health-monitoring-market

https://www.emergenresearch.com/industry-report/pompe-disease-market

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Eric Lee Emergen Research +91 90210 91709 sales@emergenresearch.com Visit us on social media: Facebook Twitter LinkedIn

EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire™, tries to define some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines for more information.

© 1995-2022 Newsmatics Inc. dba EIN Presswire All Right Reserved.